PSMA-targeted alpha therapy (Bayer AG/University of Turku)

N/A

Report date: 2025/06/11 11:17:56

Base Information

Drug NamePSMA-targeted alpha therapy (Bayer AG/University of Turku)
Drug Alias NamePSMA-targeted [225]Ac-conjugate (Bayer AG/University of Turku)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) +[4] 
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Turku
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of TurkuBayer AG
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A